• Study reports abnormally high VTE and high bleed risk in critically ill COVID-19 patients and calls for more effective prevention strategies.
  • Clinicians at NHS hospitals are supporting the care of COVID-19 patients with the use of geko™ devices to reduce the risk of blood clots in the most at risk patients.
Learn more Contact us

Our Executive Team

Firstkind is comprised of a talented and experienced founder, board of directors, and executive management team, all with successful strategic and operational expertise.

 

Bernard Ross

Founder & Chief Executive Officer

Ron Long

Executive Chairman

Francis Cooper

Chief Financial Officer

Rachel Fallon

Chief Technical Officer

Andrew Thelwell

Chief Commercial Officer

Neil Buckley

Head of Quality & Regulatory Affairs

Matthew Watts

Head of Product R&D

Mark Whalley

Head of Manufacturing & Logistics

Tony Humphrey

VP Strategy & Market Development

Sue Davenport

VP Marketing & Communications

Kieron Day

Head of Clinical Affairs